{"id":"W2984708337","doi":"10.1007/s10637-019-00875-4","title":"A phase I study of vistusertib (dual mTORC1/2 inhibitor) in patients with previously treated glioblastoma multiforme: a CCTG study","year":2019,"lang":"en","type":"article","venue":"Investigational New Drugs","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":false,"ca_institutions":"Queen's University; CancerCare Manitoba; Queen Elizabeth II Health Sciences Centre; Princess Margaret Cancer Centre; University of Calgary; Centre Hospitalier de l’Université de Montréal; University Health Network","funders":"Terry Fox Research Institute; Canadian Cancer Society","keywords":"Glioblastoma; mTORC1; Cancer research; Medicine; Dual (grammatical number); Oncology; Internal medicine; Biology; Signal transduction; Philosophy; PI3K/AKT/mTOR pathway; Genetics","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001341292,0.0002889137,0.0005274749,0.0003276113,0.00004212292,0.00002110964,0.00008295698,0.00005900944,0.00007108435],"category_scores_gemma":[0.00006999983,0.0002143117,0.00005679966,0.0006439972,0.00005955554,0.000173134,0.00004815039,0.0001400769,0.00005692865],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001927486,"about_ca_system_score_gemma":0.0003511499,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001163045,"about_ca_topic_score_gemma":0.0004095223,"domain_scores_codex":[0.9977071,0.00008631062,0.0005894488,0.0004638678,0.000885924,0.0002673688],"domain_scores_gemma":[0.9987932,0.0001036102,0.0002305289,0.0003641426,0.0002190828,0.0002893885],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001907819,0.04323415,0.9447559,0.00003311154,0.0002844913,0.00006028078,0.007981258,0.00009076289,0.000339691,0.0000178046,0.0002550824,0.001039625],"study_design_scores_gemma":[0.09886291,0.02861849,0.8673032,0.0002675024,0.0002297472,0.000004469598,0.002089408,0.0001254623,0.002248834,0.0000199527,0.00003357554,0.0001964909],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9950091,0.00002390331,2.475971e-7,0.0001215262,0.00005086466,0.00465317,0.0000219272,0.00004329146,0.00007598138],"genre_scores_gemma":[0.9993407,5.502329e-7,0.0001017883,0.00008314906,0.00004988859,0.0001718599,0.00009169553,0.00003609347,0.0001243039],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.09695508,"threshold_uncertainty_score":0.8739378,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01016463032191543,"score_gpt":0.2622984673853777,"score_spread":0.2521338370634622,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}